Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Astellas, BioFocus Sign Target Discovery Pact | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Astellas, BioFocus Sign Target Discovery Pact

SilenceSelect tech to assist CNS research

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

BioFocus has signed a collaboration agreement with Astellas Pharma focused on discovering novel targets in the field of CNS disorders. BioFocus will utilize its SilenceSelect target discovery platform to deliver validated targets to enhance the Astellas neurology pipeline and will receive research funding and success payments based on the progress of the collaboration. Financial terms were not disclosed.

“We are delighted to support Astellas Pharma in its research,” said Dr. Chris Newton, senior vice president Galapagos Services and managing director BioFocus. “Our target discovery offering allows clients to access a unique platform providing rapid identification of novel targets through a proven technology.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters